Distalmotion raises $150M to accelerate U.S. adoption of DEXTER surgical robot - The Robot Report

Distalmotion SA has raised $150 million in a Series G funding round to accelerate the commercial adoption of its DEXTER soft-tissue surgical robot in the U.S., particularly targeting the rapidly growing ambulatory surgery center (ASC) market. The company plans to use the capital to support ongoing clinical trials and product development. Founded in 2012 as a spinout from the Swiss Federal Institute of Technology in Lausanne (EPFL), Distalmotion aims to expand access to minimally invasive robotic surgery with its mobile, easy-to-use DEXTER system, which is designed to fit into operating rooms of any size without requiring modifications. The DEXTER system features fully wristed, single-use robotic instruments that enhance surgical dexterity and precision, and its sterile console allows surgeons to remain close to patients for improved workflow and communication. It supports flexible transitions between laparoscopic and robotic techniques and is compatible with existing and future operating room technologies. Commercially available in both the U.S. and Europe, the system